However, in those EBV-associated tumours that do show LMP1 expression (if not consistently), like NPC and HD, it is reasonable to conclude from the wealth of data available on LMP1 activity, that it has been factorial in the development of the tumour, as it has in these transgenic mouse tumours. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.